UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of Earliest event Reported): February ~~January 11~~13, ~~2011~~2012

China Domestica Bio-~~Technology~~ technology Holdings, Inc.

(Exact name of registrant as specified in its charter)

Nevada	000-53364	20-5432794
(State or other jurisdiction of incorporation or organization)	(Commission File Number)	(IRS Employer Identification No.)

Room 2303, 2304 ShenFang Square, 3005 RenMing

Road South, LuFung District, Shenzhen, China

(Address of principal executive offices)

Telephone – (86) 13168096855

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o £ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o £ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a -12)

o £ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))

o £ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c))

~~ITEM 4~~Item 5.~~01 CHANGES IN~~02 ~~REGISTRANT’S~~Departure ~~CERTIFYING~~of ~~ACCOUNTANT~~Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(On February 13, 2012, Qingyu Meng resigned as President and as a~~) Dismissal~~ member of the Board of Directors of China Domestica Bio-technology Holdings, Inc. (the “Company”). Mr. Meng’s resignation was due to personal reasons and not because of ~~independent~~any ~~registered~~disagreement ~~public~~with ~~accounting~~the Company ~~firm~~on any matter relating to the Company's operations, policies or practices.

On ~~January~~ 11February 16, ~~2011~~2012, the Board of Directors ofappointed ~~China Domestica Bio-Technology Holdings, Inc~~Mr., ~~a Nevada corporation (the “Company”), dismissed Seale &~~Yung ~~Beers,~~Kong ~~CPAs,~~Chin ~~Las~~as ~~Vegas,~~President ~~Nevada~~of ~~(“Seale & Beers”), as~~ the Company~~’s independent~~ ~~registered~~effective ~~public accounting firm~~immediately.

~~The report~~Mr. ofChin ~~Seale~~has ~~and~~served ~~Beers~~as on the Company’s ~~financial~~Secretary ~~statements as of and for~~since ~~the~~April ~~years ended March 31,~~ 2010 and ~~2009~~a ~~contained~~Director ~~no adverse opinion or disclaimer~~ of ~~opinion~~the ~~nor~~Company ~~was~~since ~~qualified~~June or2010. ~~modified~~Mr. asChin tograduated ~~uncertainty,~~from ~~audit scope,~~the orUniversity ~~accounting~~of ~~principle~~Hull ~~other~~in ~~than~~ the ~~following:~~United Kingdom ~~the~~with ~~report~~a Master of ~~Seale &~~Finance. ~~Beers~~Mr. ~~dated~~Chin ~~August~~served ~~31,~~as ~~2010~~president onof ~~our~~QMIS ~~financial~~Capital ~~statements~~Finance Pty. Ltd. in ~~the~~Singapore ~~Form~~and ~~10-K~~QMIS ~~for~~Capital ~~the~~Finance ~~fiscal~~Investment ~~year~~Inc. ~~ended~~from ~~March~~2003 ~~31,~~to ~~2010~~the ~~contained~~present. anPrior ~~explanatory~~to ~~paragraph which~~joining ~~noted~~QMIS, ~~that~~he ~~there~~ was ~~substantial~~a ~~doubt~~financial ascontroller tofor ~~our~~the ~~ability to continue as a~~Kwok ~~going~~Group ~~concern~~in China.

During the recent fiscal years ending March 31, 2010 and 2009 and through the date of this Current Report, there have been no (i) disagreements with Seale & Beers on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreements, if not resolved to Seale & Beers’ satisfaction, would have caused Seale & Beers to make reference to the subject matter of the disagreement(s) in connection with its reports; or (ii) “reportable events” as defined in Item 304(a)(1)(v) of Regulation S-K.SIGNATURES

~~The Company~~Pursuant ~~has~~to ~~provided~~the ~~Seale~~requirements ~~& Beers with a copy~~ of the ~~above disclosures and~~Securities ~~requested~~Exchange ~~that~~Act ~~Seale~~of &1934, ~~Beers furnish~~ the ~~Company~~registrant ~~with~~has aduly ~~letter~~caused ~~addressed~~this report to ~~the~~ ~~Securities~~be ~~and~~signed ~~Exchange~~on ~~Commission~~its ~~stating~~behalf ~~whether~~by ~~or not it agrees with~~ the ~~above~~ ~~statement.~~undersigned Ahereunto ~~copy~~duly ~~of Seale & Beers’ letter, dated January 12, 2011 is filed as Exhibit 16~~authorized.~~1 to this Current Report on Form 8-K.~~

(b) New independent registered public accounting firm

	China Domestica Bio-Technology Holdings, Inc.


Date: February 17, 2012	By:	/s/ Yung Kong Chin
		Yung Kong Chin President

On January 11, 2011, the Board of Directors of Company approved the engagement of Stan H. Lee, CPA (“Lee”), as the Company’s new independent registered public accounting firm.

During the recent fiscal years ending March 31, 2010 and 2009, and through the date of this Current Report, the Company has not consulted Lee regarding (i) the application of accounting principles to any specified transaction, either completed or proposed, (ii) the type of audit opinion that might be rendered on the Company’s financial statements, or (iii) any matter that was either the subject of a disagreement (as defined in Item 304(a)(1)(iv)) or a reportable event (as defined in Item 304(a)(1)(v)).

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS

(d) Exhibits

Exhibit No.		Description
16.1		Letter of Seale & Beers, CPAs, dated January 12, 2011

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date:	January 11, 2011
		China Domestica Bio-Technology Holdings, Inc.
		(Registrant)
		/s/ Qingyu Meng
		*Signature
		President
		Title

Filing Compare · China Domestica Bio-technology Holdings, Inc.